Skripsi
PENGARUH PEMBERIAN VITAMIN D TERHADAP PERUBAHAN KADAR PLASMA HOMA-IR, ADIPONEKTIN, HOMOSISTEIN, DAN Hs-CRP SEBAGAI BIOMARKER SINDROM METABOLIK DAN ATEROSKLEROSIS PADA PENDERITA EPILEPSI YANG MENDAPAT OBAT ANTIBANGKITAN ENZIMATIK
Introduction: Epilepsy is a manifestation of brain disorders that is associated with high morbidity. Decreased vitamin D levels and incidence of metabolic syndrome in patients receiving antiseizure medications (ASMs) have been reported. This study aimed to analyse the effect of vitamin D administration on changes in plasma levels of HOMA-IR, adiponectin, homocysteine, and hs-CRP as biomarkers of metabolic syndrome and atherosclerosis in epilepsy patients receiving enzymatic AEDs. Methods: This study encompassed a double-blind placebo-controlled randomised controlled trial (RCT) design. The intervention was vitamin D dose of 2,000 IU per day for 12 weeks. Measurements of vitamin D, HOMA-IR, adiponectin, hs-CRP, and homocysteine levels were conducted before and after the intervention and differences in levels were considered significantly different when statistical tests showed p
Inventory Code | Barcode | Call Number | Location | Status |
---|---|---|---|---|
2507004377 | T178917 | T1789172025 | Central Library (Reference) | Available but not for loan - Not for Loan |
No other version available